NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
18.35
-0.94 (-4.87%)
At close: May 8, 2026, 4:00 PM EDT
18.37
+0.02 (0.11%)
After-hours: May 8, 2026, 6:15 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $622.99 million as of May 8, 2026. Its market cap has increased by 69.08% in one year.
Market Cap
622.99M
Enterprise Value
632.77M
1-Year Change
69.08%
Ranking
Category
Stock Price
$18.35
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $622.99M, an increase of 58.41%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 622.99M | 21.14% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventus | 877.12M |
| SS Innovations International | 773.77M |
| CeriBell | 765.02M |
| QuidelOrtho | 736.46M |
| BrainsWay | 694.68M |
| Cytek Biosciences | 595.35M |
| Tactile Systems Technology | 578.57M |
| SI-BONE | 542.87M |